As of 18 Sept 2026, Q-Line Biotech Ltd share price is ₹722.10. The stock opened at ₹722.10 and had closed at ₹691.35 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹431.00 and a high of ₹735.00. In terms of performance, Q-Line Biotech Ltd share price has increased by 38.57% over the past six months and has increased by 45.67% over the last year.
QLINE Stock Price Chart
Q-Line Biotech Ltd Overview
About QLINE
Q-Line Biotech are engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs.
Q-Line Biotech Ltd Historical Performance
Q-Line Biotech Ltd Fundamentals
Q-Line Biotech Ltd Financials
| Indicator | Mar 26 | Mar 25 |
|---|---|---|
| Revenue | 346.89 | 321.90 |
| EBITDA | 103.88 | 88.38 |
| Net Profit | 56.95 | 47.40 |
| EPS | 35.55 | 30.09 |
Q-Line Biotech Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 634.58 |
| Resistance 1 (R1) | 726.53 |
| Pivot Point | 669.77 |
QLINE Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Saurabh Garg | Chairman & Managing Director |
| Kuldeep Chowdhry | Whole Time Director |
| Ajay Kumar Mahanty | Whole-time Directorector |
Q-Line Biotech Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Adani Enterprises LtdADANIENT | ₹2,924.00+0.14% | ₹2,39,561.75 | 16.95 | 3.93% |
| Premier Energies LtdPREMIERENE | ₹888.00-1.22% | ₹31,983.67 | 24.04 | 35.05% |
| Aegis Logistics LtdAEGISLOG | ₹1,353.80-1.98% | ₹22,721.99 | 23.43 | 14.83% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Q-Line Biotech Ltd today is ₹722.10 on NSE and ₹722.10 on BSE.
- The 52-week high of Q-Line Biotech Ltd is ₹735.00, while the 52-week low is ₹431.00.
- The current market capitalisation of Q-Line Biotech Ltd is approximately ₹1,685 crore.
- The P/E (Price-to-Earnings) ratio of Q-Line Biotech Ltd is 0.00. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Q-Line Biotech Ltd is 6.60. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Q-Line Biotech Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for QLINE on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Q-Line Biotech Ltd has delivered a return of approximately N/A. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Q-Line Biotech Ltd comprises different categories of shareholders. As of May 2026, the shareholding is approximately 67.51% promoters, 0.08% FIIs, 10.14% DIIs, and 15.97% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
